CN Patent

CN102105150A — 用作激酶抑制剂的磷衍生物

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2011-06-22 · 15y expired

What this patent protects

本发明涉及通式(I)化合物，其中变量基团如本文中所定义，以及涉及它们的制备和用途。

USPTO Abstract

本发明涉及通式(I)化合物，其中变量基团如本文中所定义，以及涉及它们的制备和用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN102105150A
Jurisdiction
CN
Classification
—
Expires
2011-06-22
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.